Journal
JOURNAL OF VIROLOGY
Volume 76, Issue 10, Pages 5251-5259Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.76.10.5251-5259.2002
Keywords
-
Categories
Funding
- NCI NIH HHS [CA44059, R01 CA044059] Funding Source: Medline
- NIAID NIH HHS [R01 AI034039, AI34039] Funding Source: Medline
Ask authors/readers for more resources
The vaccinia virus E3L gene encodes two double-stranded RNA binding proteins that promote viral growth and pathogenesis through suppression of innate immunity. To explore how E3L enables vaccinia virus to evade the interferon system, cells and mice deficient in the principal interferon-regulated antiviral enzymes, PKR and RNase L, were infected with wild-type vaccinia virus and strains of vaccinia virus from which E3L had been deleted (E3L-deleted strains). While wild-type virus was unaffected by RNase L and PKR, virus lacking E3L replicated only in the deficient cells. Nevertheless, E3L-deleted virus failed to replicate to high titers or to cause significant morbidity or mortality in triply deficient mice lacking RNase L, PKR, and Mx1. To investigate the underlying cause, we determined the effect of E3L on interferon regulatory factor 3 (ERF3), a transcription factor required for viral induction of subtypes of type I interferons. Results showed that IRF3 activation and interferon-P induction occurred after infections with E3L-deleted virus but not with wild-type virus. These findings demonstrate that EM plays an essential role in the pathogenesis of vaccinia virus by blocking the interferon system at multiple levels. Furthermore, our results indicate the existence of an interferon-mediated antipoxvirus pathway that operates independently of PKR, Mx1, or the 2-5A/RNase L system.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available